What is Neurocrine Biosciences's total revenue?

Neurocrine Biosciences (NBIX) reported total revenue of $814.5M in Q1 2026.

How has Neurocrine Biosciences's total revenue changed year-over-year?

Neurocrine Biosciences's total revenue increased by 42.2% year-over-year, from $572.6M to $814.5M.

What is the long-term trend for Neurocrine Biosciences's total revenue?

Over 4 years (2021 to 2025), Neurocrine Biosciences's total revenue has grown at a 26.0% compound annual growth rate (CAGR), from $1.13B to $2.86B.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Neurocrine Biosciences NBIX Total Revenue

Total Revenue at other companies

Bristol-Myers SquibbBMY

$11.49B+2.6%

Acadia PharmaceuticalsACAD

$268.06M+9.7%

Crinetics PharmaceuticalsCRNX

$10.73M+2,873%

Solid Biosciences Inc.SLDB

$2.02M-40.6%

BridgeBio PharmaBBIO

$194.52M+66.8%

BiogenBIIB

$2.48B+1.9%

Segments

By segment

See full

Reportable Segment$814.5M+42.2%

By product

See full

Collaboration revenues$3.5M-60.7%

Other financials

Income statement

See full

Gross profit$800.7M+42.1%

Operating income$193.4M+719%

Net income$197.9M+2,405%

EPS (diluted)$1.91+2,287%

Balance sheet

See full

Cash & equivalents$274.5M+35.8%

Total debt$463.5M-6.0%

Total equity$3.4B+34.4%

Total assets$4.9B+33.0%

Cash flow

See full

Operating cash flow$145.8M+125%

CapEx$9.1M-15.0%

Free cash flow$136.7M+153%

Valuation

See full

Market cap$17.3B+29.6%

Enterprise value$17.49B+28.9%

P/E25.9×-12.5×

P/S5.6×+0.3×

Profitability

See full

Gross margin98.2%-0.3pp

Operating margin25.4%+4.9pp

Net margin21.6%+8.9pp

FCF margin26.8%+6.4pp

Returns & leverage

See full

Return on equity22.5%+10.1pp

Debt / equity0.1×-0.1×

Current ratio2.9×-0.2×

Where this comes from

Reported directly by Neurocrine Biosciences in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Neurocrine Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neurocrine Biosciences's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Neurocrine Biosciences's total revenue?: Neurocrine Biosciences (NBIX) reported total revenue of $814.5M in Q1 2026.
How has Neurocrine Biosciences's total revenue changed year-over-year?: Neurocrine Biosciences's total revenue increased by 42.2% year-over-year, from $572.6M to $814.5M.
What is the long-term trend for Neurocrine Biosciences's total revenue?: Over 4 years (2021 to 2025), Neurocrine Biosciences's total revenue has grown at a 26.0% compound annual growth rate (CAGR), from $1.13B to $2.86B.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.